X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6868) 6868
Publication (1056) 1056
Book Review (589) 589
Book Chapter (40) 40
Conference Proceeding (26) 26
Dissertation (15) 15
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6221) 6221
animals (4496) 4496
humans (3265) 3265
rho-associated kinases - metabolism (2956) 2956
male (1858) 1858
rho-associated kinases (1731) 1731
phosphorylation (1712) 1712
rho-associated kinases - antagonists & inhibitors (1689) 1689
mice (1635) 1635
rats (1621) 1621
cell biology (1502) 1502
rho-associated kinase (1434) 1434
signal transduction (1371) 1371
intracellular signaling peptides and proteins (1266) 1266
pyridines - pharmacology (1240) 1240
cells, cultured (1217) 1217
amides - pharmacology (1207) 1207
protein-serine-threonine kinases - metabolism (1089) 1089
rho-kinase (1015) 1015
activation (1010) 1010
female (999) 999
rhoa gtp-binding protein - metabolism (998) 998
biochemistry & molecular biology (960) 960
enzyme inhibitors - pharmacology (930) 930
kinases (916) 916
proteins (783) 783
signal transduction - drug effects (765) 765
protein kinase inhibitors - pharmacology (764) 764
rho-associated kinases - genetics (751) 751
protein-serine-threonine kinases - antagonists & inhibitors (743) 743
protein-kinase (707) 707
expression (674) 674
actins - metabolism (664) 664
physiology (663) 663
cells (661) 661
1--2-methylpiperazine - analogs & derivatives (629) 629
rats, sprague-dawley (628) 628
pharmacology & pharmacy (625) 625
cell line, tumor (610) 610
cytoskeleton (599) 599
article (588) 588
cell line (575) 575
inhibition (569) 569
signal transduction - physiology (530) 530
apoptosis (529) 529
rho kinase (515) 515
myosin (509) 509
1--2-methylpiperazine - pharmacology (506) 506
actin (506) 506
rho gtp-binding proteins - metabolism (496) 496
oncology (491) 491
research (490) 490
rho (474) 474
rock (472) 472
smooth-muscle (465) 465
in-vivo (461) 461
gene expression (444) 444
disease models, animal (442) 442
peripheral vascular disease (442) 442
migration (439) 439
neurosciences (438) 438
blotting, western (435) 435
dose-response relationship, drug (433) 433
myosin phosphatase (430) 430
myosin light chains - metabolism (428) 428
hypertension (422) 422
muscle proteins (422) 422
physiological aspects (419) 419
analysis (413) 413
cancer (410) 410
rodents (407) 407
calcium - metabolism (405) 405
mice, inbred c57bl (400) 400
rhoa (398) 398
cardiac & cardiovascular systems (391) 391
smooth muscle (374) 374
research article (371) 371
in vitro techniques (370) 370
multidisciplinary sciences (370) 370
actin cytoskeleton (365) 365
rho-associated kinases - physiology (362) 362
fasudil (361) 361
rats, wistar (357) 357
cell movement (355) 355
protein-serine-threonine kinases - physiology (355) 355
time factors (355) 355
in-vitro (352) 352
metastasis (347) 347
phosphorylation - drug effects (336) 336
kinase (330) 330
focal adhesions (326) 326
cell adhesion & migration (322) 322
contraction (322) 322
smooth-muscle-cells (319) 319
transfection (318) 318
cell movement - drug effects (315) 315
cytoskeleton - metabolism (315) 315
signal-transduction (313) 313
medicine (312) 312
protein kinases (308) 308
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6690) 6690
Chinese (105) 105
Japanese (70) 70
Russian (8) 8
German (3) 3
Polish (3) 3
French (2) 2
Italian (2) 2
Korean (2) 2
Spanish (2) 2
Czech (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemical Journal, ISSN 0264-6021, 12/2007, Volume 408, Issue 3, pp. 297 - 315
The specificities of 65 compounds reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.... 
Drug discovery | Kinase profiling | Protein kinase | Anti-cancer drugs | Inhibitor specificity | RHO-ASSOCIATED KINASE | TUMOR PROGRESSION | FAMILY-MEMBERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CELL-PROLIFERATION | protein kinase | P38 MAP KINASE | CYCLIN-DEPENDENT KINASES | RECEPTOR TYROSINE KINASES | drug discovery | kinase profiling | SB 203580 | anti-cancer drugs | ISOFORMS IN-VITRO | P90 RSK | inhibitor specificity | Amino Acid Sequence | Cell Line | Phosphorylation | Recombinant Proteins - antagonists & inhibitors | Animals | Mitogen-Activated Protein Kinases - antagonists & inhibitors | Humans | Drug Design | Protein Kinase Inhibitors - pharmacology | Enzyme Activation | Mitogen-Activated Protein Kinases - metabolism | Spodoptera | Index Medicus | Yes1, Yamaguchi sarcoma viral oncogene homologue 1 | CSK, C-terminal Src kinase | Lck, lymphocyte cell-specific protein-tyrosine kinase | EGF, epidermal growth factor | FGF-R, fibroblast-growth-factor receptor | PAK, p21-activated protein kinase | PDK, 3-phosphoinositide-dependent protein kinase | PI3K, phosphatidylinositol (phosphoinositide) 3-kinase | NEK, NIMA (never in mitosis in Aspergillus nidulans)-related kinase | RSK, p90 ribosomal S6 kinase | HEK-293 cells, human embryonic kidney-293 cells | VEGF, vascular endothelial growth factor (vasoendothelial growth factor) | EF2K, elongation-factor-2 kinase | CK, casein kinase | PTEN, phosphatase and tensin homologue deleted on chromosome 10 | ERK, extracellular-signal-regulated kinase | ATM, ataxia telangiectasia mutated | SRPK, serine-arginine protein kinase | IL-1, interleukin 1 | MNK, MAPK-integrating protein kinase | ROCK, Rho-dependent protein kinase | CaMKK, CaMK kinase | GST, glutathione transferase | MKK1, MAPK kinase-1 (also called MEK1, MAPK or ERK kinase 1) | GAK, cyclin G-associated kinase | FMK, fluoromethylketone | MST, mammalian homologue Ste20-like kinase | PKA, cAMP-dependent protein kinase | FKBP, FK506-binding protein | PPAR, peroxisome-proliferator-activated receptor | IKK, inhibitory κB kinase | PH, pleckstrin homology | MBP, myelin basic protein | AICAR, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside | MAPKAP-K, MAPK-activated protein kinase | Sf21, Spodoptera frugiperda (fall armyworm) 21 | MARK, microtubule-affinity-regulating kinase | PIM, provirus integration site for Moloney murine leukaemia virus | LPS, lipopolysaccharide | MSK, mitogen- and stress-activated protein kinase | MAPK, mitogen-activated protein kinase | MELK, maternal embryonic leucine-zipper kinase | His6, hexahistidine | CAK, cyclin-dependent kinase-activating kinase | Eph-A2, Ephrin A2 receptor | PLK, polo-like kinase | ATF2, activating transcription factor 2 | PKD, protein kinase D | Src, sarcoma kinase | AMPK, AMP-activated protein kinase | MMS, methyl methanesulfonate | CHK, checkpoint kinase | JNK, c-Jun N-terminal kinase | TORC1, mTOR (mammalian target of rapamycin)–raptor (regulatory associated protein of mTOR) complex | BRSK, brain-specific kinase | RIP2, receptor-interacting protein 2 | IGF-1, insulin-like growth factor-1 | S6K1, S6 kinase 1 | DYRK, dual-specificity tyrosine-phosphorylated and -regulated kinase | HIPK, homeodomain-interacting protein kinase | ZMP, aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate | PRAK, p38-regulated activated kinase | PKC, protein kinase C | Src-I1, Src inhibitor 1 | TANK, TRAF (tumour-necrosis-factor-receptor-associated factor)-family-member-associated nuclear factor κB activator | NFAT, nuclear factor for activated T-cells | PHK, phosphorylase kinase | GSK3, glycogen synthase kinase 3 | PKB, protein kinase B (also called Akt) | CaMK, calmodulin-dependent kinase | CDK, cyclin-dependent protein kinase | NDRG, N-myc downstream-regulated gene | SmMLCK, smooth-muscle myosin light-chain kinase | TBK1, TANK-binding kinase 1 | PRK, protein kinase C-related kinase | SGK, serum- and glucocorticoid-induced kinase
Journal Article
Cancer Science, ISSN 1347-9032, 02/2011, Volume 102, Issue 2, pp. 393 - 399
Malignant gliomas are characterized by high invasive potential and strong angiogenic ability. Constitutive activation of Rho and its downstream target... 
FASUDIL HYDROCHLORIDE | GLIOBLASTOMA | INVASION | GTPASES | ONCOLOGY | IN-VIVO | TUMOR-CELLS | CEREBRAL VASOSPASM | LIGHT-CHAIN PHOSPHORYLATION | ENDOTHELIAL GROWTH-FACTOR | ADJUVANT TEMOZOLOMIDE | Enzyme-Linked Immunosorbent Assay | Gene Expression - drug effects | Humans | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - analogs & derivatives | Brain Neoplasms - blood supply | Extracellular Signal-Regulated MAP Kinases - metabolism | Enzyme Activation - drug effects | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Brain Neoplasms - metabolism | Glioma - metabolism | Glioma - blood supply | Cell Movement - drug effects | Mitogen-Activated Protein Kinase Kinases - metabolism | Signal Transduction - drug effects | rho-Associated Kinases - metabolism | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine - pharmacology | Cell Line, Tumor | Antineoplastic Agents - pharmacology | Neovascularization, Pathologic - metabolism | Protein Kinase Inhibitors - pharmacology | Gliomas | Analysis | Genetic research | Development and progression | Vascular endothelial growth factor | Protein kinases | Enzyme-linked immunosorbent assay | Endothelium | Protein binding | Index Medicus | Cell culture | Animal models | Phosphorylation | Invasiveness | Brain tumors | Extracellular signal-regulated kinase | MAP kinase | Matrix metalloproteinase | Endothelial cells | Gelatinase B | Rho-associated kinase | Western blotting | Polymerase chain reaction | Angiogenesis | Glioma | Glioma cells | Tumors
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 10/2011, Volume 108, Issue 42, pp. 17349 - 17354
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 07/2014, Volume 34, Issue 7, pp. 1429 - 1436
OBJECTIVE—Mitogen-activated protein kinase pathways play an important role in neointima formation secondary to vascular injury, in part by promoting... 
neointima | mitogen-activated protein kinase kinase kinase | MLK3 | PROTEIN-KINASE | DOWN-REGULATION | PROLIFERATION | HYPERPLASIA | APOLIPOPROTEIN-E | IN-VIVO | NUCLEOTIDE EXCHANGE FACTOR | PERIPHERAL VASCULAR DISEASE | GENE-TRANSFER | HEMATOLOGY | SIGNAL-REGULATED KINASE | Cell Proliferation | Hyperplasia | Myocytes, Smooth Muscle - pathology | JNK Mitogen-Activated Protein Kinases - metabolism | Neointima | MAP Kinase Kinase Kinases - deficiency | Time Factors | rho-Associated Kinases - metabolism | Carotid Arteries - enzymology | Carotid Artery Injuries - genetics | Rho Guanine Nucleotide Exchange Factors - metabolism | Myocytes, Smooth Muscle - drug effects | Carotid Artery Injuries - pathology | Disease Models, Animal | Muscle, Smooth, Vascular - drug effects | JNK Mitogen-Activated Protein Kinases - antagonists & inhibitors | Signal Transduction | MAP Kinase Kinase Kinases - genetics | Myocytes, Smooth Muscle - enzymology | Mice, Inbred C57BL | Cells, Cultured | Mice, Knockout | Muscle, Smooth, Vascular - pathology | Animals | Carotid Artery Injuries - enzymology | rho GTP-Binding Proteins - metabolism | Carotid Arteries - pathology | Mice | Protein Kinase Inhibitors - pharmacology | Muscle, Smooth, Vascular - enzymology | Index Medicus | cJun NH2-terminal kinase | p63RhoGEF | Rho-kinase | vascular smooth muscle cell | mixed-lineage kinase | RhoA
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 02/2016, Volume 126, Issue 2, pp. 560 - 570
Journal Article
Journal Article
Nature Communications, ISSN 2041-1723, 05/2016, Volume 7, Issue 1, pp. 11363 - 11363
No effective targeted therapies exist for cancers with somatic KRAS mutations. Here we develop a synthetic lethal chemical screen in isogenic KRAS-mutant and... 
CELL LUNG-CANCER | SURVIVAL | COMBINATION THERAPY | STRATEGY | MULTIDISCIPLINARY SCIENCES | SYNTHETIC LETHAL INTERACTION | RESISTANCE | MUTATIONS | RAS ONCOGENES | EXPRESSION | REVEALS | Lung Neoplasms - drug therapy | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Male | Antineoplastic Agents - administration & dosage | Lung Neoplasms - physiopathology | G2 Phase - drug effects | Tumor Suppressor Protein p53 - genetics | rho-Associated Kinases - antagonists & inhibitors | Cell Cycle Proteins - antagonists & inhibitors | Enzyme Inhibitors - administration & dosage | Cyclin-Dependent Kinase Inhibitor p21 - genetics | rho-Associated Kinases - metabolism | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Cell Cycle Proteins - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Female | Protein-Serine-Threonine Kinases - metabolism | Proto-Oncogene Proteins p21(ras) - metabolism | Lung Neoplasms - genetics | Proto-Oncogene Proteins - metabolism | Proto-Oncogene Proteins - antagonists & inhibitors | Lung Neoplasms - enzymology | Mice, Inbred C57BL | Cell Cycle Proteins - metabolism | Protein-Serine-Threonine Kinases - genetics | Tumor Suppressor Protein p53 - metabolism | rho-Associated Kinases - genetics | Proto-Oncogene Proteins - genetics | Cell Division - drug effects | Animals | Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors | Mice | Mice, Inbred BALB C | Mutation | Transcription | Polo-like kinase 1 | Lung cancer | Cyclin-dependent kinases | RhoA protein | Kinases | Rho-associated kinase | Cyclin-dependent kinase | Organic chemistry | Synergistic effects | Cyclin-dependent kinase inhibitor p21 | Transfection | DNA microarrays | Polo-like kinase | Rocks | Inhibition | Tumors | Cancer | Index Medicus
Journal Article
STEM CELLS, ISSN 1066-5099, 11/2006, Volume 24, Issue 11, pp. 2557 - 2565
The ease of isolation and ex vivo culture of marrow‐derived stromal cells (MSCs) from adult bone marrow renders them a very promising source of adult stem... 
Matrix metalloproteinases | Rho GTPases | Marrow‐derived stromal cells | ROCK MEK1/ERK | Actin cytoskeleton | Cell migration | Sphingosine‐1‐phosphate | MEK1/ERK | ROCK | Marrow-derived stromal cells | Sphingosine-1-phosphate | GLIOMA-CELLS | PAXILLIN | marrow-derived stromal cells | BONE-MARROW | CANCER | MESENCHYMAL STEM-CELLS | SPHINGOSINE 1-PHOSPHATE | CELL & TISSUE ENGINEERING | CELL BIOLOGY | actin cytoskeleton | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | cell migration | sphingosine-1-phosphate | FOCAL ADHESION KINASE | GROWTH-FACTOR | RHO-GTPASES | HEMATOLOGY | matrix metalloproteinases | MOTILITY | Paxillin - metabolism | Phosphorylation | Bone Marrow Cells - enzymology | rhoA GTP-Binding Protein - metabolism | Intracellular Signaling Peptides and Proteins - metabolism | Dose-Response Relationship, Drug | Stromal Cells - enzymology | Actin Cytoskeleton - drug effects | rho-Associated Kinases | Lysophospholipids - pharmacology | Protein-Serine-Threonine Kinases - antagonists & inhibitors | Bone Marrow Cells - drug effects | Female | Indoles - pharmacology | Flavonoids - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Amides - pharmacology | MAP Kinase Kinase 1 - antagonists & inhibitors | Actin Cytoskeleton - metabolism | Focal Adhesion Protein-Tyrosine Kinases - metabolism | Intracellular Signaling Peptides and Proteins - antagonists & inhibitors | Mice, Inbred C57BL | Stromal Cells - metabolism | Cells, Cultured | Enzyme Inhibitors - pharmacology | MAP Kinase Kinase 1 - metabolism | Chemotaxis - drug effects | Hydroxamic Acids | Cell Shape - drug effects | Sphingosine - pharmacology | Sphingosine - analogs & derivatives | Animals | MAP Kinase Signaling System - drug effects | Matrix Metalloproteinase Inhibitors | Mice | Pyridines - pharmacology | Matrix Metalloproteinases - metabolism | Bone Marrow Cells - metabolism | Index Medicus
Journal Article
JAMA Ophthalmology, ISSN 2168-6165, 07/2015, Volume 133, Issue 7, pp. 755 - 761
Journal Article
Journal Article
Theriogenology, ISSN 0093-691X, 04/2017, Volume 92, pp. 176 - 189
Journal Article